Synergy between interleukin-1β, interferon-γ and glucocorticoids to induce TLR2 expression involves NF-κB, STAT1 and GR

Akanksha Bansal; Cora Kooi; Keerthana Kalyanaraman; Sachman Gill; Andrew Thorne; Priyanka Chandramohan; Amandah Necker-Brown; Mahmoud M Mostafa; Arya Milani; Richard Leigh; Robert Newton

doi:10.1124/molpharm.123.000740

Article Information

MOLPHARM-AR-2023-000740

DOI

https://doi.org/10.1124/molpharm.123.000740

PubMed

37863662

Published By

American Society for Pharmacology and Experimental Therapeutics

Print ISSN

0026-895X

Online ISSN

1521-0111

History

Published online October 20, 2023.

© 2023 The Authors. This is an open access article under the terms of the Creative Commons Attribution CC BY License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Author Information

Akanksha Bansal1,
Cora Kooi2,
Keerthana Kalyanaraman2,
Sachman Gill2,
Andrew Thorne2,
Priyanka Chandramohan2,
Amandah Necker-Brown2,
Mahmoud M Mostafa2,
Arya Milani2,
Richard Leigh3, and
Robert Newton1,*

¹Physiology and Pharmacology, University of Calgary, Canada
²Physiology & Pharmacology, University of Calgary, Canada
³Department of Medicine, University of Calgary, Canada

↵* Corresponding Author:
Robert Newton, Physiology and Pharmacology, University of Calgary, 3330 Hospital Drive NW, Faculty of Medicine, Calgary, T2N 4N1, Canada. E-mail: rnewton{at}ucalgary.ca